The carboxylic acid functional group of ibuprofen [a-methyl-4-(2-methylpropyl)benzene acetic acid] is reduced to the corresponding alcohol and subsequently esterified to the acetate derivative by cultures of Nocardia species strain NRRL 5646. The alcohol and ester microbial transformation products were isolated, and their structures were determined by 'H and 13C nuclear magnetic resonance spectroscopy and mass spectrometry. By derivatization of synthetic and microbiologically produced ibuprofen alcohols with S(+)-Oacetylmandelic acid, nuclear magnetic resonance analysis indicated that the carboxylic acid reductase of Nocardia sp. is R enantioselective, giving alcohol products with an enantiomeric excess of 61.2%. The R enantioselectivity of the carboxylic acid reductase enzyme system was confirmed by using cell extracts together with ATP and NADPH in the reduction of isomeric ibuprofens.
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Microorganisms and their enzymes have received much attention and are widely used as a class of biocatalytic reagents in synthetic organic chemistry (5, 8, 10, (14) (15) (16) (17) (18) (19) (20) (21) 25) . Biocatalysts are valued for their intrinsic abilities to bind organic substrates and to catalyze highly specific and selective reactions under the mildest of reaction conditions. These selectivities and specificities are realized because of highly rigid interactions occurring between the enzyme active site and the substrate molecule. Useful biocatalytic reactions that have been well developed to date include a variety of oxidations, reductions, hydrolyses, and carbon-carbon bond ligations. Enzyme reactions such as those catalyzed by esterases, for example, may be used either hydrolytically or to synthesize esters, depending on the reaction medium, which may be aqueous or organic in composition.
Biocatalytic reactions are particularly useful when they may be used to overcome difficulties encountered in catalysis achieved by the use of traditional chemical approaches. The reduction of carboxylic acids by microorganisms is a relatively new biocatalytic reaction that has not yet been widely examined or exploited. Jezo and Zemek reported the reduction of aromatic acids to their corresponding benzaldehyde derivatives by actinomycetes (9) . Kato et al., reported the reduction of benzoate to benzyl alcohol by a Nocardia strain (13) , and Tsuda et al. described the reduction of 2-aryloxyacetic acids (23) and arylpropionates (24) by Glomerella species and Gloeosporium species. Carboxylic acid reduction reactions catalyzed by several additional microorganisms have been described recently by Arfmann and Abraham (1) .
Ibuprofen is a 2-arylpropionic acid derivative, and it is a potent oral nonsteroidal antiinflammatory, antipyretic, and analgesic agent (11, 22) . Pharmacological activities of ibuprofen reside almost exclusively in its S enantiomer (7) . This is the first report which describes microbial transformations of ibuprofen. We describe the bioconversion of ibuprofen and ibuprofen isomers to the corresponding alcohol and acetate derivatives by Nocardia sp. strain NRRL 5646 and the stereoselectivity of these bioconversion reactions. (2) in 25 ml of sterile soybean meal-glucose medium held in stainless-steel-capped, 125-ml DeLong culture flasks. The medium contained (weight/ volume) 2% glucose, 0.5% yeast extract, 0.5% soybean meal, 0.5% NaC1, and 0.5% K2HPO4 in distilled water and was adjusted to pH 7.0 with 6 N HCI and then autoclaved at 121°C for 15 Rates of microbial transformations of ibuprofen. The standard two-stage fermentation procedure was used for kinetic experiments in which the rates of ibuprofen conversion and alcohol and acetate formation were determined. Racemic ibuprofen, S(+)-ibuprofen, and R(-)-ibuprofen were each added to duplicate, 125-ml flasks which contained 25 ml of medium and 1 mg of substrate per ml. Substrate-containing cultures were sampled at various time intervals by removing 1 ml of the entire culture. The internal standard, (+)-naproxen (0.5 mg), was added to the samples. Samples were adjusted to pH 2 with 6 N HCl extracted with 5 ml of ethyl acetate, and the organic and aqueous layers were separated by centrifugation for 1 min in a desktop centrifuge. A 1-ml volume of the organic extract was removed, evaporated to dryness under N2, and reconstituted in 1 ml of HPLC-grade methanol for quantitative analysis by HPLC. The results of microbial transformations of R(-)-and S(+)-ibuprofen can be seen in Fig. 3A and B, respectively.
Cell-free enzymatic reduction of ibuprofen to ibuprofenol. Cultures were grown as usual by the fermentation procedure for 24 h. An inducer, sodium benzoate, was directly added to the cultures at 5 mg/ml. Cultures were taken at 48 h, filtered through cheesecloth, and centrifuged at 8,000 x g for 10 min. The resulting cell paste (5 g, wet weight) was suspended in 25 ml of cold 50 mM Tris-HCl buffer (pH 7.5), and the suspension was disrupted for 5 min Fig. 2A and B 24 and 72 h of incubation, and an additional spot appeared when cultures were incubated for 120 h. No similar running products were observed in chromatograms of extracts from cultures containing no ibuprofen.
A preparative-scale incubation of Nocardia sp. with 1 g of racemic ibuprofen gave three products which were extracted and purified by silica gel column chromatography (100 g of silica gel, 3 by 35 cm) by elution with benzene-acetic acid (99:1, vol/vol) for structure analysis. A total of 338 mg of recovered compound 1, 283 mg of metabolite 2, and 92 mg of metabolite 3 were characterized as described below.
Schemes of ibuprofen, metabolites, and derivatives are given in Fig. 1 (3) were also derivatized and analyzed by NMR ( Fig. 2A and B , respectively). In the 600-MHz spectra of the S(+)-O-acetylmandelates (Fig. 2) , the signal at 2.158 ppm represents the O-acetyl methyl group of the R(+)-ibuprofenol enantiomer, while the signal at 2.167 ppm represents the O-acetyl methyl group of the S(-)-ibuprofenol enantiomer. Since the signals for acetyl methyl groups were well resolved, it was possible to use these to ascertain the enantiomeric purities of racemic ibuprofenol ( Fig. 2A) , S(-)-ibuprofenol (Fig. 2B) , and ibuprofenol obtained from the microbial reduction reaction ( 3A) were nearly 100%, while that for S(+)-ibuprofen ( Fig. 3B) was only about 60%. After peak levels of products were formed, there was a gradual decline in levels of ibuprofen and metabolites 2 and 3, and no new metabolites were detected. The rate of R( -)-ibuprofen whole-cell biotransformation was nearly twice that obtained with either racemic or S(+)-ibuprofen. An initial lag of about 10 h was observed in the reduction of S(+)-ibuprofen before rapid conversion of substrate to products occurred. There was no apparent lag in the reduction of the enantiomeric R( -)-ibuprofen isomer. No S(-)-ibuprofenol acetate was formed during whole-cell biotransformations of S(+)-ibuprofen (Fig. 3B) .
Active in assigning the stereochemistries of secondary alcohols. The derivatization reaction is quantitative in nature, and we have used this approach to ascertain the stereochemical purities of other microbiologically produced secondary alcohols (6, 16) . Ibuprofenol obtained by saponification of the acetate ester was of similar enantiomeric composition. These results complement those obtained with recovered and unreacted ibuprofen, and they confirm that the nature of the carboxylic acid reductase enzyme system is R( -)-ibuprofen specific.
The rates of biotransformation of ibuprofens were evaluated with whole cultures and HPLC analysis of the resulting products. The reduction of R(-)-ibuprofen occurred without an apparent lag (Fig. 3A) , and the rate of R(-)-ibuprofen reduction was estimated to be twice that for S(+)-ibuprofen. There was an apparent lag of about 10 h prior to the reduction of S(+)-ibuprofen by Nocardia sp. (Fig. 3B) . This observation suggests the possibility that Nocardia sp. strain NRRL 5646 contains an inducible carboxylic reductase enzyme system for the S(+)-ibuprofen isomer similar to that described by Kato et al. (12) for benzoate reduction. In these analytical experiments, mass balances accounting for substrate used and metabolites produced were high between 50 and 70 h for R(-)-and racemic ibuprofens. However, after 100 h of incubation, no new products were observed and the levels of ibuprofen and metabolites 2 and 3 declined, indicating that further degradation of the metabolites occurs. The lack of an ibuprofenol acetate as a metabolite with S(+)-ibuprofen incubations (Fig.  3B ) was surprising.
Carboxylic acid reductases are complex, multicomponent enzyme systems which require the initial activation of carboxylic acids via formation of AMP and possibly coenzyme A intermediates. The reduction of the activated carboxylic acid intermediate occurs stepwise to give aldehyde and then alcohol products (9, 12) . It was possible to establish a relatively stable and active crude, cell-free carboxylic acid reductase system that required ATP and NADPH for the reduction reaction. The enzyme system is inducible with benzoate, and properties of the carboxylic acid reductase enzyme system of Nocardia sp. strain NRRL 5646 are similar to those described by Kato et al. for benzoate reduction in Nocardia asteroides (12) . The cellfree preparation was used to demonstrate that the rate of reduction of R(-)-ibuprofen was four times faster than that for S(+)-ibuprofen. These results confirm the R( -)-enantioselective properties of the carboxylic acid reductase enzyme system of Nocardia sp. strain 5646. We are presently working to establish the properties and scope of the carboxylic acid reductase enzyme system of nocardiae.
